Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-11-02

Clinical Trial Update: Evaluation of Safety and Diabetes Status Upon Oral Treatment With GABA in Patients With Longstanding Type-1 Diabetes [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating the safety and diabetes status during oral GABA treatment in patients with longstanding Type 1 Diabetes has been completed…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • GABA (gamma-aminobutyric acid)

Snippet

Sponsor: Per-Ola Carlsson | Conditions: Type 1 Diabetes Mellitus | Phase 1, Phase 2 | Status: COMPLETED